Source comparison
MK-677 vs HGH Comparison: Cost Breakdown and Results Timeline
Cost differential isn't just about manufacturing complexity. It reflects regulatory classification and supply chain structure. Research-grade MK-677 from facilities like Real Peptides runs $80–150 per month for daily 25mg dosing when purchased in bulk lyophili
This comparison does not assign a generated winner or score.
- Cost differential isn't just about manufacturing complexity. It reflects regulatory classification and supply chain structure. Research-grade MK-677 from facilities like Real Peptides runs $80–150 per month for daily 25mg dosing when purchased in bulk lyophilized form. Pharmaceutical somatropin prescribed through anti-aging or hormone optimization clinics costs $500–2,000+ monthly depending on dosage (typically 2–6 IU daily) and whether insurance covers any portion. Generic biosimilar HGH from international sources may drop to $200–400 monthly, but quality verification becomes the researcher's burden.
- Results timelines diverge as sharply as costs. MK-677 researchers report subjective improvements in sleep quality and recovery within 7–14 days, measurable increases in IGF-1 by week 3–4, and observable changes in body composition (reduced visceral adiposity, increased lean mass) after 12–16 weeks of consistent dosing. The GHRH/ghrelin synergy study published in Growth Hormone & IGF Research found that 25mg daily MK-677 increased fat-free mass by 1.1 kg over 8 weeks in younger adults. Modest but statistically significant without dietary intervention.
- HGH produces faster initial changes because serum levels spike immediately. Researchers administering 4 IU daily somatropin typically observe improved recovery markers within the first week, visible reduction in subcutaneous adiposity by week 4–6, and meaningful lean mass gains (2–4 kg) within 12 weeks when paired with resistance training. A Phase 3 trial in adults with GH deficiency showed 0.6 mg/day somatropin increased lean body mass by 2.1 kg over 6 months versus placebo. The effect scales with dose and training stimulus.
- Here's what most comparison charts miss: MK-677's effects plateau around week 16–20 as the body adapts to sustained ghrelin receptor activation, while HGH's effects continue scaling with dose escalation until side effects become limiting. MK-677 won't produce the same magnitude of change as 6 IU daily HGH. The mechanisms don't support equivalent outcomes. Our team has reviewed this across hundreds of research protocols. The pattern is consistent: MK-677 produces moderate, sustainable improvements; HGH produces dramatic, dose-dependent changes with higher risk profiles.